✎ Dr. Alexandra LaStella, Pharm.D, RPh alexandra.lastella14@gmail.com doi: 10.70390/75sdfxt9 Bell’s palsy (BP) is a sudden, temporary...

Metabolic syndrome (MetS) has rapidly evolved into one of the most pressing global health crises. Defined by a cluster of interconnected risk factors: abdominal obesity, dyslipidemia, hypertension, and insulin resistance, MetS significantly elevates the risk of cardiovascular disease (CVD), type 2 diabetes (T2DM), and other chronic conditions.

Transhumanism is a philosophy and social movement that advocates for using advanced science and technology to enhance human capabilities—particularly in extending lifespan, improving cognition, and refining physical appearance. As pharmacists, it's essential to evaluate which of these enhancements are nearing clinical application, to assess their pharmacologic rationale, and to anticipate where ethical and safety concerns may arise in caring for patient populations.

For over thirty years, the Beers Criteria have shaped how clinicians approach medication safety in older adults. But is it time to rethink their scope?

Naltrexone, a widely recognized opioid receptor antagonist, has been primarily used at standard doses of 50–100 mg daily to treat opioid and alcohol use disorders. Recent studies, however, reveal its versatility across a broader dosing spectrum. This review examines the therapeutic effects and safety profiles of naltrexone across three dosing strategies...

✎ Dr. Katherine Gabriel, PharmD, RPh ORCiD:   0009-0004-0341-9744 Background The weight loss drug market is on fire, fueled by...